This compound is primarily researched for its potential in cancer therapy. It functions as a potent and selective inhibitor of cyclin-dependent kinase 9 (CDK9), which plays a critical role in transcription regulation and cancer cell survival. By inhibiting CDK9, it disrupts the transcription of key survival genes in cancer cells, leading to their apoptosis. This makes it a promising candidate for treating various cancers, particularly those resistant to conventional therapies. Current studies focus on its efficacy in hematologic malignancies and solid tumors, with ongoing clinical trials to evaluate its safety and effectiveness in humans.